---
source_image: "bank-statement+invoice__EFTA01289201_20260130_p234_i001.png"
source_pdf: "EFTA01289201.pdf"
method: pdf_text
words: 520
confidence: 1.00
extracted: 2026-02-13T16:08:35.920800
---

a Deutsche Bank 
P.O. Box 1776, Baltimore, MD 21203 
Portfolio Holdings Disclosures (continued) 
January 1,2017 - January 31, 2017 
SOUTHERN FlNA NCIAL LLC 
Option Disclosure (continued) 
financial situation. Expiring options w hich are valuable are exercised automatically pursuant to the exercise by exception procedure of the Options Clearing Corporation. Additional 
information regarding this procedure is available upon written request to your introducing firm. 
Foreign Currency Transactions 
Pershing may execute foreign currency transactions as principal for your account. Pershing may automatically convert foreign currency to or from U.S. dollars for dividends and similar 
corporate action transactions unless you instruct your financial organization otherwise. Pershing's currency conversion rate will not exceed the highest interbank conversion rate 
identified from customary banking sources on the conversion date or the prior business day, increased by up to 1%, unless a particular rate is required by applicable law. Your financial 
organization may also increase the currency conversion rate. This conversion rate may differ from rates in effect on the date you executed a transaction, incurred a charge, or 
received a credit. Transactions converted by agents (such as depositories) will be billed at the rates such agents use. 
Proxy Vote 
Securities not fully paid for in your margin account may be lent by Pershing to itself or others in accordance with the terms outlined in the Margin Agreement. The right to vote your 
shares held on margin may be reduced by the amount of shares on loan. The Proxy Voting Instruction Form sent to you may reflect a smaller number of shares entitled to vote than 
the number of shares in your margin account. 
Ratings 
This statement may contain credit rating information obtained from Standard & Poor's. Reproducing and distributing any information received from Standard & Poor's is not permitted 
without prior written authorization from Standard & Poor's Standard & Poor's does not guarantee the accuracy, completeness, timeliness or availability of any information. Standard & 
Poor's is not responsible for any errors or omissions, regardless of the cause, or for the results of using such content. Standard & Poor's makes no express or implied warranties 
including warranties of merchantability or fitness for a particular purpose. Standard & Poor's shall not be legally responsible for any fees, costs, expenses or losses in connection with 
the use of their content. Credit ratings are opinions and not statements of facts; are not recommendations to purchase. hold or sell securities. and do not address suitability for 
investment purpose. Credit ratings should not be relied upon as investment advice.
Schedule of Realized Gains and Losses Current Period 
Date 
Date 
Realized 
Description 
Disposed 
Acquired 
Designation 
Disposition Method; Transaction 
Quantity 
Proceeds 
Cost Bois 
Gain Loss 
Long Term 
ARIAD PHARU ACEUTICAL 
01113117 
02114112 
Noncoveree.13
First In Fug 0u1/ SELL 
7,535.000 
178,048.44 
114,597.40 
63.451.04 
Secutily Identifier. 040334110 
01113117 
01/24113 
*Dowered "3
First In First OA i SELL 
9,000.000 
212,665.68 
176.400.00 
36.265.68 
Total 
16,535 000 
390,714.12 
290,997.40 
99,716.72 
Page $.1 of 17 
CONFIDENTIAL — PURSUANT TO FED. R. CRIM. P. 6(e) 
CONFIDENTIAL 
is pandas 
borne 9.• lMl 
Owed 
Is *ad es v.* 
SONO Wier 
lk 
Maki Wel aitfaidelaa1 SCOrdmarso 
Idabel 
MUM 
P's "`"ilArtit0004o462 
DB-SDNY-0009286 
EFTA_0015707 I 
EFTA01289434
